<?xml version="1.0" encoding="UTF-8"?>
<list list-type="simple" continued-from="list2" id="list3">
 <list-item>
  <label>18</label>
  <p>How pathogenic to humans are the various predicted pandemic influenza viruses?</p>
 </list-item>
 <list-item>
  <label>19</label>
  <p>What are the human health and wellbeing impacts of agricultural and wild plant and animal pathogen outbreaks?</p>
 </list-item>
 <list-item>
  <label>20</label>
  <p>What are the economic, societal and biodiversity impacts of wildlife diseases in the UK?</p>
 </list-item>
 <list-item>
  <label>21</label>
  <p>What are the consequences of failing to contain the rise of antimicrobial resistant infections and what are the best mitigation methods?</p>
 </list-item>
 <list-item>
  <label>22</label>
  <p>How does changing land use affect the spread and impact of pathogens?</p>
 </list-item>
 <list-item>
  <label>23</label>
  <p>What disease risks are associated with the changing distribution and ecology of arthropod disease vectors?</p>
 </list-item>
 <list-item>
  <label>24</label>
  <p>What new or increased pathogen and pest threats will the UK face in a world changed by different climate change and human development pathway scenarios?</p>
 </list-item>
 <list-item>
  <label>25</label>
  <p>What are the within-host evolutionary pathways for avian influenza viruses to evolve to transmit amongst humans, and the probability of their occurence?</p>
 </list-item>
 <list-item>
  <label>26</label>
  <p>Of the phenotypic changes needed for a non-human influenza virus to adapt into a pandemic virus in humans, which ones already exist in circulating non-human viruses worldwide?</p>
 </list-item>
 <list-item>
  <label>27</label>
  <p>What amino acid substitutions are necessary to make avian non-human influenza viruses in different subtypes and genetic lineages transmissible among humans and cause an influenza pandemic?</p>
 </list-item>
 <list-item>
  <label>28</label>
  <p>What technological and other approaches can improve wild and agricultural plant and animal disease surveillance in the UK?</p>
 </list-item>
 <list-item>
  <label>29</label>
  <p>How can new technologies be used in syndromic surveillance systems, including detection thresholds, for disease threats in the UK, to more effectively identify unusual events and reduce time to alert?</p>
 </list-item>
 <list-item>
  <label>30</label>
  <p>What tools could most effectively improve the detection of slowly-spreading epidemics, such as HIV, vCJD or cancer-causing pathogens such as HPV?</p>
 </list-item>
 <list-item>
  <label>31</label>
  <p>To what extent can social media platforms be usefully integrated into early detection/warning systems in the UK?</p>
 </list-item>
 <list-item>
  <label>32</label>
  <p>What approaches are possible to protect against currently unknown emerging infectious diseases and how cost-effective might they be?</p>
 </list-item>
 <list-item>
  <label>33</label>
  <p>How can we better understand and model human behaviour during disease outbreaks, including deliberate release events?</p>
 </list-item>
 <list-item>
  <label>34</label>
  <p>How do we best mobilise the human resources required in health, and veterinary and vector control, services at the speed necessary to treat human patients and control a serious outbreak?</p>
 </list-item>
 <list-item>
  <label>35</label>
  <p>If human quarantine were required, how could it be effectively implemented and which actions would most effectively achieve compliance?</p>
 </list-item>
</list>
